ProMIS Neurosciences Inc.
PMNNasdaqCIK 1374339HealthcareFiscal year ends Dec 31
Reports and events: 91 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1320:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-095905 |
| 2026-08-1320:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-095895 |
| 2026-07-2810:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-087269 |
| 2026-05-2020:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-064545 |
| 2026-05-1212:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-059035 |
| 2026-05-1210:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-058967 |
| 2026-04-0920:01 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001104659-26-041483 |
| 2026-03-2520:34 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-034554 |
| 2026-03-2512:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-034162 |
| 2026-02-0500:02 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-005412 |
| 2026-02-0221:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-004760 |
| 2026-01-3013:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-008325 |
| 2025-12-1621:48 ET | 8-K | 8.01 Other events | 0001104659-25-121627 |
| 2025-11-2413:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-115182 |
| 2025-11-1914:25 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-113978 |
| 2025-11-1212:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-109719 |
| 2025-11-1212:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-109714 |
| 2025-10-2920:30 ET | SCHEDULE 13D | Ownership report, active investor | 0001493152-25-020081 |
| 2025-10-2420:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-102137 |
| 2025-10-0320:15 ET | DEF 14A | Proxy statementPeriod 2025-11-17 | 0001104659-25-096657 |
| 2025-09-3020:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-095032 |
| 2025-09-0311:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-011845 |
| 2025-08-1920:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-25-011671 |
| 2025-08-1311:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011299 |
| 2025-08-1311:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011297 |
| 2025-07-2811:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-009636 |
| 2025-07-2220:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-009380 |
| 2025-07-2210:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events | 0001558370-25-009352 |
| 2025-07-0720:45 ET | 8-K | 8.01 Other events | 0001558370-25-009112 |
| 2025-06-1312:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-25-008600 |
| 2025-05-1211:39 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007255 |
| 2025-05-1211:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007253 |
| 2025-04-2921:14 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001558370-25-005871 |
| 2025-03-3111:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-004070 |
| 2025-03-3111:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-004068 |
| 2025-02-2512:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-001435 |
| 2025-02-1921:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-25-001158 |
| 2025-01-2712:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-000427 |
| 2025-01-1012:29 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000095 |
| 2025-01-0822:10 ET | 8-K | 3.01 Delisting notice | 0001558370-25-000075 |
| 2024-11-1414:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015634 |
| 2024-11-1414:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015632 |
| 2024-10-2420:05 ET | 8-K | 5.07 Shareholder vote results | 0001558370-24-013616 |
| 2024-10-1020:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-013244 |
| 2024-09-0920:05 ET | DEF 14A | Proxy statementPeriod 2024-10-23 | 0001558370-24-012683 |
| 2024-08-0812:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011476 |
| 2024-08-0812:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011474 |
| 2024-07-2912:45 ET | 8-K | 8.01 Other events | 0001558370-24-010257 |
| 2024-07-2612:52 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-010224 |
| 2024-07-2612:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-010223 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.